{"id":"W3204395813","doi":"10.1093/eurheartj/ehab674","title":"Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement","year":2021,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":595,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; National Institutes of Health; Incyte; National Cancer Institute; Brigham and Women's Hospital; British Heart Foundation; Takeda Oncology; Austrian Science Fund; Amgen; Ariad Pharmaceuticals; Daiichi-Sankyo; Teva Pharmaceutical Industries; Acorda Therapeutics; Children's Discovery Institute; National Heart, Lung, and Blood Institute; Vifor Pharma; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Intensive care medicine; Clinical trial; Cancer; Clinical Practice; Heart failure; Internal medicine; Oncology; Family medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001501896,0.0001504685,0.0004810192,0.00005972657,0.00014987,0.00004956175,0.00009295595,0.00006152684,0.0003405924],"category_scores_gemma":[0.00006710719,0.0001407303,0.0007830784,0.0001106771,0.0001145976,0.0001023003,0.00004277164,0.0004303155,0.00000930945],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000289214,"about_ca_system_score_gemma":0.0005358925,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002577606,"about_ca_topic_score_gemma":0.000006162269,"domain_scores_codex":[0.9979486,0.0005787156,0.0004501338,0.0002383816,0.000548018,0.0002361775],"domain_scores_gemma":[0.9988515,0.00006678507,0.0001557761,0.0002855011,0.0004718961,0.0001685219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003009464,0.0003297895,0.03101015,0.0001197485,0.01050394,0.001121761,0.0163737,0.001761824,0.8359856,0.0002621452,0.01020638,0.09202399],"study_design_scores_gemma":[0.005134948,0.0005354194,0.05141472,0.0003914121,0.0004074835,0.004996205,0.01208242,0.0001361042,0.3627118,0.00005987788,0.5618148,0.000314837],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9771149,0.01035122,0.0005731997,0.002098059,0.000859294,0.0001273058,0.00003477624,0.00003385352,0.008807456],"genre_scores_gemma":[0.9869486,0.00556583,0.004414888,0.001637098,0.001129729,0.000003547505,0.0000256894,0.00004333751,0.000231294],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5516084,"threshold_uncertainty_score":0.5738815,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05349346076954907,"score_gpt":0.3487774273703979,"score_spread":0.2952839666008488,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}